NCT04034251 Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis Status TERMINATED Phase PHASE2
NCT04008511 Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT03959150 Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT03958721 Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer Status COMPLETED Phase PHASE1
NCT03950154 Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT03930771 Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas Status TERMINATED Phase PHASE2
NCT03929666 A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer Status COMPLETED Phase PHASE2
NCT03923166 Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT03921684 Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03916510 Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1
NCT03907475 Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial Status RECRUITING Phase PHASE2
NCT03901339 Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT03889626 The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer Status UNKNOWN Phase PHASE3
NCT03887130 Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT03878524 Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial Status TERMINATED Phase PHASE1
NCT03873532 A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT03872388 Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy Status TERMINATED Phase PHASE2
NCT03869892 Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy. Status ACTIVE_NOT_RECRUITING Phase PHASE3